Ensuring Cost Savings for Heart Patients
The government promised seniors lower prescription drug prices with through setting price standards and caps on out-of-pocket costs. Unfortunately, instead of saving money, out-of-pocket costs on select cardiovascular treatments have increased by 32 percent. Learn more and lend your voice in support of protecting patients costs.
Studies suggest that health plans that administer Part D will increase financial exposure because of the reforms Congress implemented in 2022 that were meant to help patients. PBMs and their health plans are already blunting their financial impact by increasing average out-of-pocket costs by 32% in 2025 for medications that have had their price capped by Medicare.
Graphics
Some Seniors Are Paying 32% More For Their Prescriptions
Social media graphic
Pharmacy Benefit Managers
Social media graphic
Government Price Fixing
Social media graphic
Papers
Formulary Guidance
According to recent studies, unchecked tactics from pharmacy benefit managers (PBMs) are leaving Medicare patients with increased costs for the treatments they need.
Videos
Why Are Heart Patients Paying More Under Price Controls?
Despite price controls, prescription drug costs have gone up--especially for patients on Medicare. See how middlemen are distorting prices for America's seniors and hurting heart patients the most.